WallStSmart

McCormick & Company Incorporated (MKC-V)vsSRx Health Solutions Inc. (SRXH)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

McCormick & Company Incorporated generates 60038% more annual revenue ($7.69B vs $12.78M). MKC-V leads profitability with a 19.4% profit margin vs 0.0%. SRXH trades at a lower P/E of 0.0x. MKC-V earns a higher WallStSmart Score of 59/100 (C).

MKC-V

Buy

59

out of 100

Grade: C

Growth: 4.7Profit: 7.5Value: 8.0Quality: 5.0
Piotroski: 4/9Altman Z: 1.58

SRXH

Avoid

34

out of 100

Grade: F

Growth: 2.7Profit: 2.5Value: 6.7Quality: 5.3
Piotroski: 2/9Altman Z: -5.50
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MKC-VUndervalued (+77.9%)

Margin of Safety

+77.9%

Fair Value

$325.30

Current Price

$47.52

$277.78 discount

UndervaluedFair: $325.30Overvalued

Intrinsic value data unavailable for SRXH.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MKC-V4 strengths · Avg: 8.8/10
P/E RatioValuation
8.4x10/10

Attractively priced relative to earnings

Return on EquityProfitability
21.4%9/10

Every $100 of equity generates 21 in profit

Price/BookValuation
1.8x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
17.4%8/10

17.4% revenue growth

SRXH2 strengths · Avg: 10.0/10
P/E RatioValuation
0.0x10/10

Attractively priced relative to earnings

Price/BookValuation
0.1x10/10

Reasonable price relative to book value

Areas to Watch

MKC-V3 concerns · Avg: 3.3/10
PEG RatioValuation
2.044/10

Expensive relative to growth rate

Altman Z-ScoreHealth
1.584/10

Distress zone — elevated risk

EPS GrowthGrowth
-57.1%2/10

Earnings declined 57.1%

SRXH4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$24.02M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : MKC-V

The strongest argument for MKC-V centers on P/E Ratio, Return on Equity, Price/Book. Profitability is solid with margins at 19.4% and operating margin at 17.8%. Revenue growth of 17.4% demonstrates continued momentum.

Bull Case : SRXH

The strongest argument for SRXH centers on P/E Ratio, Price/Book.

Bear Case : MKC-V

The primary concerns for MKC-V are PEG Ratio, Altman Z-Score, EPS Growth.

Bear Case : SRXH

The primary concerns for SRXH are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

MKC-V profiles as a growth stock while SRXH is a value play — different risk/reward profiles.

MKC-V is growing revenue faster at 17.4% — sustainability is the question.

MKC-V generates stronger free cash flow (112M), providing more financial flexibility.

Monitor PACKAGED FOODS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MKC-V scores higher overall (59/100 vs 34/100), backed by strong 19.4% margins and 17.4% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

McCormick & Company Incorporated

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

McCormick & Company is an American multinational food company that manufactures, markets, and distributes spices, seasoning mixes, condiments, and other flavoring products to retail outlets, food manufacturers, and foodservice businesses.

SRx Health Solutions Inc.

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

SRx Health Solutions Inc. provides healthcare and medical treatment services.

Visit Website →

Want to dig deeper into these stocks?